Clinical trial

Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)

NCT03053297

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Patient Reported Outcomes Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)

Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2017-03-01

PhaseN/A

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

Patient Reported OutcomesOTHER

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

TorontoOntario, Canada1 MadridSpain1 BarcelonaSpain1 LondonUnited Kingdom1 ParisFrance1 MontrealQuebec, Canada1 BeijingBeijing Municipality, China1 ShanghaiShanghai Municipality, China1 TaipeiTaiwan1 GuangzhouGuangdong, China1 ToulouseFrance1 SevilleSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03053297 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.